# Carlsmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carlsmed

- Industry: Medical Devices & Equipment
- Headquarters: Carlsbad, US
- Website: www.carlsmed.com
- Total disclosed funding: $84M
- Latest round: Series C (Mar 12, 2024)
- Investors on record: 6

## About

Founded in 2018 and based in California, US, Carlsmed, Inc. operates as a medical technology company. The company was founded by its CEO, Mike Cordonnier, and Niall Casey. In March 2024, B Capital Group, Vertical Group, and US Venture Partners co-led a USD 38.5 million series C funding for Carlsmed, Inc. The Series C funding values Carlsmed, Inc. at USD 201.07 million post-money.

Carlsmed develops and sells the aprevo® spine fusion devices. The company’s AI-enabled personalized surgery platform uses patient-specific data and digital technologies to create customized surgical plans and implants.

The company plans to use the funds raised in March 2024 to support the development of a platform for personalized spine surgery.

## Funding rounds

- Series C, Mar 12, 2024, $39M — US Venture Partners, Vertical Group, B Capital
- Series B, Apr 18, 2022, $30M — US Venture Partners, Vertical Group, B Capital, Cove Fund, Wavemaker Three-Sixty Health
- Series A, Dec 15, 2020, $13M — US Venture Partners, Vertical Group, Cove Fund, Wavemaker Three-Sixty Health
- Seed, Jun 23, 2020, $2.5M — Cove Fund, Wavemaker Three-Sixty Health, Tomorrow Capital

## Investors

- Cove Fund (https://capitalatlas.ai/funds/cove-fund) — Seed, Series A, Series B
- Wavemaker Three-Sixty Health (https://capitalatlas.ai/funds/wavemaker-three-sixty-health) — Seed, Series A, Series B
- Tomorrow Capital (https://capitalatlas.ai/funds/tomorrow-capital) — Seed
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series A, Series B, Series C
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series A, Series B, Series C
- B Capital (https://capitalatlas.ai/funds/b-capital) — Series B, Series C